Long‐term safety, tolerability and efficacy of bosentan in adults with pulmonary arterial hypertension associated with congenital heart disease

OBJECTIVE: To examine long‐term safety and efficacy of bosentan—an oral dual endothelin receptor antagonist—in patients with pulmonary hypertension associated with congenital heart disease or Eisenmenger's syndrome. DESIGN: Retrospective study. SETTING: Tertiary cardiology referral centre. PATI...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Diller, Gerhard‐Paul, Dimopoulos, Konstantinos, Kaya, Mehmet G, Harries, Carl, Uebing, Anselm, Li, Wei, Koltsida, Evdokia, Gibbs, J Simon R, Gatzoulis, Michael A
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Group 2007
Assuntos:
Pulmonary Hypertension
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1994431/
https://ncbi.nlm.nih.gov/pubmed/17639112
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/hrt.2006.089185
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados